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Abstract rTMS is increasingly used for a variety of neu-
ropsychiatric conditions. There are data to support ‘fast’
rTMS (C10 Hz) having some positive effects on cognitive
functioning, but a dearth of research looking at any such
effects of ‘slow’ rTMS. This question is important as cog-
nitive dysfunction accompanies many neuropsychiatric
conditions and neuromodulation that potentially enhances or
hinders such functioning has important clinical conse-
quences. To determine cognitive effects of slow (B1 Hz)
rTMS, a systematic review of randomized control trials
assayed cognition in neurological, psychiatric, and healthy
volunteer B1 Hz rTMS paradigms. Both active (fast rTMS)
and placebo comparators were included. 497 Records were
initially obtained; 20 met inclusion criteria for evaluation.
Four major categories emerged: mood disorders; psychotic
disorders; cerebrovascular accidents; and ‘other’ (PTSD,
OCD, epilepsy, anxiety, and tinnitus). Cognitive effects
were measured across several domains: attention, executive
functioning, learning, and psychomotor speed. Variability of
study paradigms and reporting precluded meta-analytical
analysis. No statistically significant improvement or deteri-
oration was consistently found in any cognitive domain or
illness category. These data support the overall safety of
rTMS in not adversely affecting cognitive functioning.
There are some data indicating that rTMS might have cog-
nitive enhancing potential, but these are too limited at this
time to make any firm conclusions, and the literature is
marked by considerable heterogeneity in study parameters
that hinder interpretation. Greater consensus is required in
future studies in cognitive markers, and particularly in
reporting of protocols. Future work should evaluate the
effects of rTMS on cognitive training.
Keywords rTMS  Cognition  Systematic review 
Neuropsychiatry
Introduction
Transcranial magnetic stimulation (TMS) is a non-invasive
cortical modulating tool, where a fluctuating magnetic field
induces an electrical current that depolarises underlying
neurons (Wassermann et al. 2008). Repetitive TMS (rTMS)
can be applied as either low (B1 Hz) or high (C5 Hz) fre-
quency; the former considered typically inhibitory to
underlying neurons, the latter excitatory (Pell et al. 2011).
The effects on distal but functionally connected regions may
be more complex (Tracy et al. 2011, Tracy et al. 2014).
rTMS alters synaptic plasticity through long-term
potentiation (LTP) and long-term depression (LTD) changes
(Hoogendam et al. 2010); however, the underlying mecha-
nisms of these effects are not fully understood (Pell et al.
2011; Ridding and Rothwell 2007). Rodent studies demon-
strate that rTMS increases the expression of genes important
for synaptic plasticity, such as c-Fos (Aydin-Abidin et al.
2008; Doi et al. 2001), but at present, data on rTMS-induced
intracellular changes in gene expression, protein synthesis,
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or other alterations to secondary messenger signalling are
largely understudied (Hulme et al. 2013).
The ability to modulate cortical activity—relatively
easily, painlessly, and without the use of a general anaes-
thetic—has garnered significant interest concerning poten-
tial clinical application. In psychiatric populations, the utility
of rTMS in depression and psychosis has been most studied,
and a recent systematic review of meta-analyses supports a
modest effectiveness in both of these conditions (Hovington
et al. 2013). Nascent positive results have also been obtained
in the treatment of anorexia nervosa (Van den Eynde et al.
2013), bulimia nervosa (Van den Eynde et al. 2010),
obsessive–compulsive disorder (OCD) (Berlim et al. 2013;
Greenberg et al. 1997; Mantovani et al. 2010), tinnitus
(Khedr et al. 2010; Kleinjung et al. 2005; Landgrebe et al.
2013; Langguth et al. 2003), and stroke (Khedr et al. 2009;
Kim et al. 2006; Takeuchi et al. 2008). However, the litera-
ture is overall marked by often conflicting results between
trials and considerable methodological concerns about study
size and the lack of consensus on optimal rTMS technique
parameters (Tracy and David 2015).
In cognitive neuroscience, TMS has been utilised as a tool
to disrupt normal cortical activity as a means of better elu-
cidating various cognitive processes (Miniussi and Rossini
2011; Tracy et al. 2015; Wassermann et al. 2008). Typically,
non-repetitive TMS is applied during the execution of a
cognitive task (so-called ‘‘online TMS’’), and a transient
disruption of normal functioning (a ‘‘virtual lesion’’) is
induced allowing inferences to be made about the role of the
stimulated brain area in the cognitive task (Miniussi et al.
2010; Wassermann et al. 2008). For example, Gough et al.
2005 determined that three pulses of TMS to the anterior left
inferior frontal cortex (LIFC) delivered at 100 ms intervals
caused a significant slowing of response in a semantic
judgement task, but not in a phonological judgment task; and
conversely that TMS given to the posterior LIFC caused a
significant slowing of response in the phonological task, but
not in the semantic one (Gough et al. 2005). The effects of
offline stimulation on cognitive functioning, with task exe-
cution and TMS stimulation temporally dissociated, have
also been investigated (Demirtas-Tatlidede et al. 2013;
Miniussi and Rossini 2011). Studies have largely focussed
on cognitive recovery after stroke, prolonged psychiatric
disease, or traumatic brain injury. No conclusive evidence is
currently available regarding the use of offline non-invasive
brain stimulation for the rehabilitation of such neuropsy-
chiatric disease, though undoubtedly such work is still at a
nascent stage (Demirtas-Tatlidede et al. 2013).
Most data on cognitive effects of TMS in studies on
participants with mental illness come from clinical trials
where they are often reported as part of safety and side-
effects assessments (Demirtas-Tatlidede et al. 2013).
Contrary to electroconvulsive therapy (ECT) (Schulze-
Rauschenbach et al. 2005), the majority of studies show
that rTMS has no clear deleterious effects, though the
secondary nature of such data collection means that overall
there is a dearth of information on this topic (Anderson
et al. 2006; Guse et al. 2010). Some clinical trials have
found rTMS to be associated with improvements across
several cognitive domains (Fitzgerald et al. 2009; Hoppner
et al. 2003). For example, Mogg et al. (2007) found that
10 Hz rTMS led to a significant improvement in verbal
learning among patients with schizophrenia, whilst Martis
et al. (2003) found that 10 Hz rTMS resulted in significant
improvements across various cognitive domains, including
executive functioning and memory among patients with
depression (Mogg et al. 2007).
In addition to focusing on psychiatric applications, an
increasing number of studies are now addressing the
potential therapeutic effects of rTMS in the context of
cognitive neurorehabilitation (Miniussi and Rossini 2011;
Stuss 2011). Indeed, 10 Hz rTMS was associated with a
significant improvement in executive functioning among
patients with cerebrovascular disease (Rektorova et al.
2005). Problematically, depression, schizophrenia, and
cerebrovascular disease are associated with illness-driven
state-based cognitive difficulties, for example, driven
through neuropsychological processes, such as low mood,
impaired attention, and concentration. Thus, rTMS-induced
improvements in cognition may be—at least partially—
through ameliorating individuals’ mental states rather than
primarily enhancing cognition.
Aim
To date, the majority of studies investigating the effects of
rTMS on cognitive functioning have used high-frequency
stimulation, though this might be an artefact of fast rTMS
being the most common paradigm, particularly in depres-
sion. A systematic review found that, in most studies, high-
frequency rTMS had no significant effect on cognition
(Guse et al. 2010). There was, however, variation: several
studies reported improvements and three studies deteriora-
tion in cognitive functioning. Further studies have demon-
strated no effect of high-frequency rTMS on working
memory (Guse et al. 2013) and verbal and figural fluency
(Schaller et al. 2013) in healthy patients. However, Guse
et al. (2013) suggest a role for high-frequency rTMS in
cognitive neuroprotection from the loss of working memory
in schizophrenia. To date, there has been no systematic
review of the effects of low-frequency rTMS on cognitive
functioning despite low-frequency rTMS remaining a com-
mon clinical paradigm, particularly in psychosis. This paper
aimed to systematically review the literature for the effects
of slow (\1 Hz) rTMS in cognition.
Lage et al.
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Method
Eligibility criteria
These were defined a priori using the PICOS components
(participants, interventions, comparators, outcomes, and
study design) as defined by the PRISMA statement on
systematic reviews (Liberati et al. 2009).
Participants Subjects without pervasive developmental
disorders and neurodegenerative diseases; with any psy-
chiatric disorder, neurological condition; and healthy were
considered for inclusion. No restrictions regarding age or
other population characteristics were applied.
Interventions Only studies using 1 Hz rTMS, which is
utilised by the majority of low-frequency rTMS studies,
were considered. No restrictions regarding other rTMS
parameters were applied. Studies with online rTMS para-
digms designed to induce virtual lesions were excluded, as
these typically evaluate very specific neurocognitive sub-
domains, and their generalisability to cognitive functioning
in the wider clinical populations is challengeable; and
studies with 1 Hz rTMS administered in combination with
other frequencies were also excluded.
Comparators Both active (e.g., high-frequency rTMS)
and placebo (e.g., sham rTMS) interventions were con-
sidered. No restrictions were applied.
Outcomes Studies with one or more objective assess-
ments of cognitive functioning were considered. No further
restrictions were applied.
Study design Only randomized trials were considered for
inclusion.
Literature search
Four separate electronic searches were performed using
Medline (Ovid), Embase (Ovid), PsycInfo (Ovid), and the
Cochrane Library as databases. Databases were last searched
in September 2014. The following search terms were used:
repetitive transcranial magnetic stimulation, rTMS, cognition,
neurocognitive, neuropsychological, attention, reaction time,
executive function, memory, learning, and processing speed.
The search limits applied were English language, publication
years from 1992 until 2014 and randomized trials.
Study selection
All records obtained from the electronic searches were
sequentially screened on the basis of title and abstract:
those that clearly did not meet the eligibility criteria were
excluded, and duplicates were removed. The full texts were
examined by two of the authors (C.L. and D.K.T.) for the
remaining studies.
Data extraction
A data extraction form was developed based on the
guidelines of the Cochrane Collaboration (Green 2011).
The form was piloted on half of the included studies and
revised accordingly. The following data were extracted
from each: source, study design, total number of partici-
pants, sex, age, diagnosis, medication, location (of
administered rTMS), number of sessions per week, fre-
quency, coil type, total number of pulses per session, train
duration and inter-train interval, intensity, compara-
tor/control group, outcomes, and results.
Risk of bias assessment
The Cochrane Collaboration’s bias assessment software
was used to measure the validity of each included study
(Green 2011).
Data analysis
Due to overall heterogeneity of participants, rTMS
parameters, comparator groups, and cognitive measure-
ments, statistical combination of results for meta-analytical
comparison was not considered valid. A narrative synthesis
was deemed the most suitable method of data analysis. The
following elements were addressed: design paradigm,
neurocognitive effects, and risk of bias. Studies were
organised by clinical groups namely: mood disorders,
psychotic disorders, and stroke, with a fourth group,
including all other single studies (epilepsy, OCD, tinnitus,
and healthy participants). Full comparison of individual
studies, including study size, design, parameters, and
cognitive measures, used are available in the supplemen-
tary material.
Results
Search and selection of studies
497 records were initially obtained, and 308 excluded,
because of evident lack of relevance to the eligibility cri-
teria. 90 duplicates were removed, and the eligibility of the
remaining 99 studies was further assessed: 41 studies were
excluded, because they did not meet the intervention cri-
teria; 2 did not meet comparator criteria; 30 did not meet
outcome criteria; 5 did not meet the study design criteria;
and 1 study was excluded, because of overlap of patient
data with one of the included studies. This initial search
yielded 20 studies (Fig. 1).
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Characteristics of included studies
Fifteen out of the 20 included studies were randomized,
double-blind, sham-controlled studies, with two of these
having a cross-over design. The remaining five studies
consisted of two randomized double-blind non-sham-con-
trolled cross-over studies; one randomized blind sham-
controlled cross-over study; one randomized blind study;
one blind randomized sham-controlled study; and one
randomized open study (Table 1). Overall, the studies had
small sample sizes, with the lowest number being four
participants and the highest 60 (mean 29.95, SD 19.13).
The participants’ ages ranged from 16 to 79 (not all studies
reported a mean). Eight studies included patients with
mood disorders; five included patients with psychotic dis-
orders (schizophrenia and schizoaffective disorder); four
studies involved stroke patients; and the remaining were
individual studies of epilepsy, OCD, tinnitus, with one
comprised healthy participants. The supplementary
tables provide details of the extracted data.
The 1 Hz rTMS parameters differed substantially in the
location of the stimulus, the number of rTMS sessions, the
number of pulses per session, the motor threshold (MT),
and the outcome measures. Areas to which rTMS was
applied included the primary motor cortex (PMC), the left
temporoparietal cortex (TPC), and the left or right dorso-
lateral prefrontal cortex (DLPFC).
The latter was the most frequently selected option. The
total number of rTMS sessions ranged from one to 20, with
ten sessions (five per week) being the mode. The inter-
vention duration additionally varied from 1 day to 4 weeks.
In 16 of the 20 included studies, the total number of pulses
per session and the train duration/inter-train interval were
either not reported or not sufficiently clearly reported.
Amongst the remaining studies, these parameters differed
substantially. The intensity of rTMS also varied across
studies, however, in the majority, it ranged between 80 and
110 % of the MT. Three different comparator groups were
used: high-frequency rTMS (10 or 20 Hz), sham stimula-
tion, and, in one study, electroconvulsive therapy (ECT).
40 different tests assessing cognitive domains were used
across studies.
Timing of cognitive measure
The time between rTMS and neurocognitive testing was
evaluated. All 20 studies performed baseline testing prior
to rTMS intervention. 18 of the 20 included studies per-
formed cognitive testing immediately after completing the
last session of rTMS. Of the other two, one (Januel et al.
2006) performed testing half way through the 4 weeks of
rTMS; and one (Thiel et al. 2013) did post-treatment
testing, but did not clarify when this occurred. 11 out of the
20 papers reported follow-up cognitive assessment after
rTMS. The mean time from the final session to follow-up
was 32.3 days (SD 29.08). The shortest time to follow-up
was 3 days and the longest 105 days (15 weeks). 7 studies
did not report follow-up and 2 were not clear as to the
follow-up. One of the studies did not report follow-up
(Januel et al. 2006); one of the studies was not clear as to
follow-up (Thiel et al. 2013).
Neurocognitive effects of low-frequency rTMS
Due to the variety of outcome measures reported, the data
were tabulated according to mental illness, broadly: mood
disorders, psychotic disorders, cerebrovascular accident,
and ‘‘other’’ (encompassing PTSD, OCD, epilepsy,
497 records obtained through electronic search es
Databases: Medline (n=169), Embase (n=126),  Psychinfo (n=61), Cochrane Library (n=141)
497 records screened (title and abstract)
97 full text studies assessed for eligibility 
after duplicates removed (n=90)
28 studies considered for inclusion in the
systematic review
20 studies included in the systematic
review
308 records excluded
71 studies excluded
8 studies excluded
Fig. 1 Flow diagram of study selection
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anxiety, and tinnitus). A further categorization into neu-
rocognitive domains assessed by the outcome measure used
in each study was performed to facilitate cross-comparison.
These categories were attention, executive function/work-
ing memory, learning and memory, and psychomotor speed
and processing. No statistically significant improvement or
deterioration was found in any one cognitive domain across
the disease categories. Two papers (Fitzgerald et al. 2005;
Hansen et al. 2011) reported statistically significant dete-
rioration and in the cognitive domain of verbal fluency and
retrieval. Furthermore, the majority of papers reported no
significant improvement across the cognitive domains
(Table 2).
Risk of bias
Studies were also marked with asterisks according to the
strength of their methodology (*** = Low-bias risk,
** = Medium-bias risk, and * = High-bias risk). Bias
assessment was calculated using RevMan 5.1 (Fig. 2).
Categories of bias included randomization, allocation
concealment, blinding of participants and personnel,
blinding of outcome assessment, incomplete outcome data,
selective outcome reporting, and others. Studies were rated
as high risk, medium risk, and low risk depending on the
highest risk level of any individual subcategory. Selective
reporting was the most common serious source of bias in
the studies ([50 % of included studies, see Fig. 2).
Discussion
This systematic review overall supports the general safety
of rTMS and lack of harm to cognitive functioning (An-
derson et al. 2006; Guse et al. 2010). Only two studies
reported a significant deterioration (Fitzgerald et al. 2005;
Hansen et al. 2011) in the cognitive domain of verbal
fluency and retrieval. However, one study (Fitzgerald et al.
2009) found a significant improvement in verbal fluency
after rTMS and three studies (Fregni et al. 2006b; Little
et al. 2000; Speer et al. 2001) demonstrated no significant
effect. The inconsistency of these results may reflect the
variation in the methods and outcomes used to assess the
impact of 1 Hz rTMS on cognitive functioning. In partic-
ular, over 40 different tests assessing various cognitive
domains were used with large timing variations as to when
subjects were assessed at follow-up. Furthermore, the risk
of bias hinders the validity of results, with selective out-
come reporting being of particular concern. Incomplete and
inadequate outcome reporting is potentially a consequence
of cognitive assessment being a secondary outcome in the
majority of studies.
Technical factors
Type of coil and sham technique
Several coil factors may influence the effects of rTMS: the
type of coil used, sham technique, and positioning during
the trial (Lang et al. 2006). Two types of coil were used,
the figure of eight coil and the circular coil. Circular coils
produce a diffuse magnetic field over a large area and due
to this lack of focality they are less used (Wassermann
et al. 2008). The adequacy of the sham conditions can be
challenged in some studies: in several, it involved placing
the coil at a 45 angle away from the skull, which has been
shown to still modulate cortical activity (Lisanby et al.
2001; Loo et al. 2000). For example, Lisanby et al.
demonstrated that the tilt-induced voltage levels only 24 %
below those of active stimulation (Lisanby et al. 2001).
Furthermore, one study did not provide detail regarding the
degree of tilt (McIntosh et al. 2004). Tilt may also affect
blinding due to sensory differences to motor threshold
(MT) assessments prior to treatment (Fregni et al. 2006c).
Similarly, in those studies using a sham coil, different scalp
sensations could unblind patients not naı¨ve to rTMS
(Fregni et al. 2006b). The purpose of sham conditions
remains to find a protocol that mimics the cutaneous
Table 1 Characteristics of included studies
# of
studies
Studies Randomized Double-
blind
Single-
blind
Sham-
control
Cross-
over
Open
13 Fitzgerald et al. (2005), Fregni et al. (2006a, b), Hoffman et al.
(2005, 2013), Hoppner et al. (2003), Januel et al. (2006), Kang et al.
(2009), Kim et al. (2010), Koren et al. (2001), Schneider et al. (2008),
Thiel et al. (2013), Waldowski et al. (2012)
9 9 9
2 McIntosh et al. (2004), Speer et al. (2001) 9 9 9 9
2 Fitzgerald et al. (2009), Little et al. (2000) 9 9 9
1 Smith et al. (2007) 9 9 9 9
1 Watts et al. (2012) 9 9 9
1 Hansen et al. (2011) 9 9
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Table 2 Cognitive effects of low-frequency rTMS
Disorder Cognitive domain Improvement No effect (ns) Deterioration
Mood
disorder
Attention
Selective/focussed attention Speer et al. (2001)*, Little et al. (2000)**,
Januel et al. (2006)*, Hoffman et al.
(2005)*
Sustained attention/concentration Hoppner et al. (2003)* Speer et al. (2001)*, Hansen et al. (2011)***
Executive functions/working memory
Working memory (short-term
storage/manipulation/monitoring)
Fitzgerald et al. (2009)* Hoffman et al. (2005)*, Watts et al. (2012)*
Cognitive flexibility Fitzgerald et al. (2009)* Speer et al. (2001)*, Januel et al. (2006)*
Verbal fluency/retrieval Fitzgerald et al. (2009)* Little et al. (2000)**, (Speer et al. 2001)* Hansen et al.
(2011)***
Learning and memory (intermediate-/long-term storage)
Verbal learning ? memory Little et al. (2000)* Hoffman et al. (2005)*, Hansen et al.
(2011)***
Spatial learning ? memory/
objective learning ? memory
Little et al. (2000)**, Speer et al. (2001)*,
Januel et al. (2006)*
(Visual) associative
learning ? memory
Hansen et al. (2011)*** Fitzgerald et al. (2009)*
Psychomotor speed
Psychomotor speed/processing
speed
Hoppner et al. (2003)* Speer et al. (2001)*, Januel et al. (2006)*,
Watts et al. (2012)*
Psychotic
illness
Attention
Selective/focussed attention Hoffman et al. (2005)*
Executive functions/working memory
Working memory (short-term
storage/manipulation/monitoring)
Hoffman et al. (2005)*
Cognitive flexibility Hoffman et al. (2013)*, Schneider
et al. (2008)*
Hoffman et al. (2005)*
Verbal fluency/retrieval Fitzgerald
et al.
(2005)*
Learning and memory (intermediate-/long-term storage)
Verbal learning ? memory Hoffman et al. (2013)*, Fitzgerald et al.
(2005)*, McIntosh et al. (2004)*
Psychomotor speed
Psychomotor speed/Processing
speed
Hoffman et al. (2005)*
Stroke Attention
Alertness/simple reaction Waldowski et al. (2012)***
Selective/focussed attention Fregni et al. (2006a)***, Kim et al.
(2010)***
Executive functions/working memory
Working memory (short-term
storage/manipulation/monitoring)
Fregni et al. (2006a)***, Kim et al.
(2010)***
Cognitive flexibility Fregni et al. (2006a)***, Kim et al.
(2010)***
Verbal fluency/retrieval Fregni et al. (2006a)***
Learning and memory (intermediate-/long-term storage)
Verbal learning ? memory Thiel et al. (2013)*** Kim et al. (2010)***
(Visual) Associative
learning ? memory
Kim et al. (2010)***
Psychomotor speed
Psychomotor speed/processing
speed
Kim et al. (2010)***
Lage et al.
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feelings of rTMS (Arana et al. 2008), but thus far, an
adequate protocol has yet to be found (Rossi et al.
2001, 2009).
Coil positioning
Coil positioning varied between trials. One method
involves locating the desired area of stimulation based on
its spatial relationship to a functionally determined area,
such as the motor cortex (Sparing et al. 2008). For exam-
ple, to place the coil on the left DLPFC, five centimetres
are measured anteriorly in a parasagittal plane from the
location where the MT is determined (Nahas et al. 2007).
However, the individual-level precision of such generic
localisation can be challenged. For example, Herwig et al.
found that the 5 cm standard method of locating the
DLPFC was accurate in only 7 of 22 included participants
(Herwig et al. 2001). Another method of coil positioning
uses the electroencephalographic (EEG) international
10–20 system (Jasper 1958), relying on the location of
cranial landmarks (e.g., nasion and preauricular points)
with the coil placed at set distances from these landmarks
(Nahas et al. 2007): once again, this technique is hindered
by inter-individual morphological variation (Rusjan et al.
2010).
To improve the precision of stimulation, an increasing
number of studies use neuronavigational methods to guide
coil positioning e.g. (Herwig et al. 2003; Luber et al. 2008;
Smith et al. 2007). Optical frameless stereotaxic systems
incorporate imaging data and enable the coil to be posi-
tioned via three-dimensional navigation (Lefaucheur 2010;
Sparing et al. 2008). Imaging data can be obtained on an
individual basis using magnetic resonance imaging (MRI),
functional MRI (fMRI) or positron emission tomography
(PET), or utilising probabilistic imaging data from large
data sets (Lefaucheur 2010; Sparing et al. 2008). However,
despite the prima facie improvement in accuracy offered by
neuronavigation, a large randomized controlled trial failed
to demonstrate superior efficacy of fMRI-guided rTMS was
not superior to conventionally applied rTMS or sham
stimulation among patients with treatment-resistant audi-
tory verbal hallucinations (AVH) (Slotema et al. 2011).
Table 2 continued
Disorder Cognitive domain Improvement No effect (ns) Deterioration
Other
Organic
Disease
Attention
Alertness/simple reaction Smith et al. (2007)*, Fregni et al.
(2006b)***, Koren et al. (2001)*
Selective/focussed attention Fregni et al. (2006b)***, Kang et al.
(2009)***
Executive functions/working memory
Working memory (short-term
storage/manipulation/monitoring)
Fregni et al. (2006b)*** Kang et al. (2009)***
Cognitive flexibility Fregni et al. (2006b)*** Kang et al. (2009)***
Psychomotor speed
Psychomotor speed/processing
speed
Koren et al. (2001)*
*** Low-bias risk, ** Medium-bias risk, * High-bias risk
Fig. 2 Risk of bias per domain
for the included studies
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Stimulation protocol
Stimulus intensity is determined in relation to the MT
(Nahas et al. 2007), and in the majority of studies, it ranged
between 80 and 110 % of the MT. Such variation may
affect the consistency of results; work on corticospinal
excitability has shown, for example, that 115 % rTMS led
to a reduction in motor evoked potentials (MEPs), whereas
when given at 85 % of the MT, it did not (Fitzgerald et al.
2002). The choice of correct MT threshold has been rela-
tively underexplored in clinical rTMS protocols despite
evidence to suggest that both age and medication exhibit
significant effects on the MT.
rTMS is known to be less effective among older par-
ticipants (Figiel et al. 1998; Su et al. 2005). One expla-
nation for this is the increased distance between scalp and
cortex among older adults due to age-related cerebral
atrophy, with the strength of the magnetic field drops
exponentially with distance from the coil (Wassermann
et al. 2008). To compensate for cerebral atrophy, the
intensity of rTMS can be adjusted considering that the rate
of atrophy is not symmetrical across cortical areas (Stokes
et al. 2005, 2007). In a sample of depressed patients with
an age range of 55–75 years with MT adjusted for distance
between the scalp and the cortex, the intensity of rTMS
ranged from 103 to 141 % of the MT. Out of 18 patients,
four achieved remission and a further five were partial
responders (Nahas et al. 2004). These results suggest that
correcting for age-related atrophic changes may improve
rTMS outcomes in older patients.
Medication may also affect the required rTMS stimulus
intensity, and, for example, both the antidepressants
citalopram (Minelli et al. 2010; Robol et al. 2004) and
clomipramine (Minelli et al. 2010) have been shown to
increase the necessary MT. AEDs, such as lamotrigine and
phenytoin, increase the MT due to their blocking action on
voltage-sensitive sodium channels (Paulus et al. 2008;
Wassermann et al. 2008). Long-term use of benzodi-
azepines also significantly increases the MT (Palmieri et al.
1999). The majority of participants in the included studies
were on psychotropic medication that may have affected
cognitive functioning and cortical excitability, although
this was inconsistently reported in trials, and few evaluated
this as a confounder. Anti-epileptic drugs (AEDs),
antipsychotics, antidepressants, and benzodiazepines all
have potential adverse cognitive side effects (Drane and
Meador 2002; Elie et al. 2009; Hori et al. 2012; Schachter
2007). Evaluation of drug effects can be difficult due to the
considerable variation between the various drugs, individ-
ual susceptibility to side effects, and fluid changes in
cognition from functional aspects of the illness itself. For
any meaningful comparison to be made between studies,
full reporting of study design must be undertaken.
If comparisons are to be made between studies, report-
ing of study design is of paramount importance. Stimula-
tion parameters, including the number of pulses, the train
duration/inter-train interval, and the number of sessions
varied considerably or were not consistently recorded: 16
out of the 20 studies did not adequately report these
parameters.
Age is also a confounding factor, and similarly under-
explored, in relation to neurocognitive testing. In addition
to age-related changes to the MT, age-related decline of
performance on various cognitive tasks is well docu-
mented, e.g., (Brickman et al. 2007; Wielgos et al. 1999).
The age range of participants in the included studies was
16–79 and a wide age range was used in each individual
study. However, most studies did not report the mean age
of their participants making it impossible to draw any
conclusions.
Conclusion
In summary, no definite conclusions can be drawn at this
time, regarding the effects of 1 Hz rTMS on cognitive
functioning. Calling for more research is futile if that
research can produce no meaningful conclusions: to date
the lack of unambiguous findings is not due solely to a lack
of research—though the field remains underexplored—but
is far more hindered by methodological issues. Neverthe-
less, there are lessons to be learned regarding protocols for
rTMS use, confounding factors in studies, and a theory of
pre-conditioning and post-conditioning that could greatly
improve the quality and applicability of rTMS in mood
disorders, psychotic illness, stroke, epilepsy, and other
disorders.
There are several clear areas that future research in this
field will need to address. The obvious area of need is
standardisation—or at least adequate reporting—across
several domains: technical; rTMS protocols; and neu-
rocognitive outcome measures. This is true of the broader
neuromodulatory field, not limited to cognitive effects.
Individual trials are unlikely to be sufficiently powered to
elucidate all of these factors, but if they are at least
appropriately reported, then bigger data set analysis of
these and demographic factors will allow valid cross-
comparison and meta-analytic analysis of future work.
The figure of eight coil has largely superseded the cir-
cular coil, and it is unlikely much future work will be
undertaken with the latter. Blinding and sham condition
paradigms remain problematically inconsistent, but despite
the issue of the lack of sensation, sham coils appear a better
proposition than coil tilting. With regard to coil siting,
whilst we note the negative findings of Sloetma et al., it is
our opinion that neuronavigation is an inherently superior
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paradigm as its functional approach addresses individual
variation. However, further studies are warranted if this
argument is to be proved or disproved.
Standardised cognitive batteries would hugely facilitate
across-study comparisons and the replication of studies.
The MATRICs initiative in schizophrenia studies is a
worthy reference point in this regard. As with MATRICS,
good test–retest reliability, practicality of test usage, rela-
tionship to functional outcome, response to pharmacolog-
ical adjuncts, and use as a repeated measure should be
characteristics of the included tests (Green et al. 2004).
Such protocol consistency is, especially, important given
that any protocol discrepancies are compounded by con-
founding factors intrinsic to the populations studied: in
particular, age-related changes in cognition and concomi-
tant pharmacotherapy.
Finally, it may be the case that pre-conditioning and
post-conditioning of the brain are necessary to take full
advantage of the positive effects of rTMS. This hypothesis
of pre-conditioning the brain is already borne out through
studies on the effects of pharmaceuticals in rTMS studies
(Fregni et al. 2006a), in which the effects of 1 Hz rTMS
depended on the state of cortical excitability at the time of
stimulation.
In addition to pharmaceutical pre-conditioning, studies
have used transcranial direct current stimulation (tDCS) to
modulate the effects of 1 Hz rTMS. Siebner et al.
demonstrated that excitatory anodal tDCS caused 1 Hz
rTMS to further reduce cortical excitability, whereas
inhibitory cathodal tDCS led to an increase in excitability
following 1 Hz rTMS (Siebner et al. 2004). Similarly, Iyer
et al. found that 6 Hz rTMS enhanced the inhibitory effects
of 1 Hz rTMS (Iyer et al. 2003). The same pattern of
results was also obtained by Lang et al., in which the
direction of 5 Hz rTMS was determined by preceding
tDCS conditioning of motor cortex excitability (Lang et al.
2004). These findings have potentially important implica-
tions for the included studies with a cross-over design, e.g.,
(Fitzgerald et al. 2009; Little et al. 2000). Since some of
these studies crossed-over patients from low-frequency
rTMS to high-frequency rTMS and vice versa, it is possible
that carry-over effects confounded the results, but also that
cross-over studies may compound positive effects.
A further point in this regard is that there is reasonably
good basic neuroscience data that rTMS can enhance
neuronal plasticity—the mechanism, indeed, that would
underlie any putative cognitive enhancement. However,
with this in mind, there is an obvious dearth of utilising
parallel cognitive remediation during the trial rTMS
period.
rTMS has been in existence since the 1980s. Despite this,
and the ongoing interest in its potential clinical roles, it
remains incompletely understood. There are data to support
its utility in several neuropsychiatric disorders and, some-
what more speculatively, to enhance cognition. At this time,
it remains unclear how much the somewhat ambivalent data
represent the technique’s fundamental limitations, and how
much the numerous confounders are clouding any underly-
ing improvement. If practical aspects mean that smaller
study size remain the norm, this should at least be done
within the context of standardised reporting that will allow
work to fit within bigger subsequent data sets.
Compliance with ethical standards
Conflict of interest The authors have no financial or other conflict of
interest.
Funding No funding or financial support was provided for the con-
duct of this research.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
Anderson B, Mishory A, Nahas Z, Borckardt JJ, Yamanaka K,
Rastogi K, George MS (2006) Tolerability and safety of high
daily doses of repetitive transcranial magnetic stimulation in
healthy young men. J ECT 22:49–53
Arana AB et al (2008) Focal electrical stimulation as a sham control
for repetitive transcranial magnetic stimulation: Does it truly
mimic the cutaneous sensation and pain of active prefrontal
repetitive transcranial magnetic stimulation? Brain Stimul
1:44–51
Aydin-Abidin S, Trippe J, Funke K, Eysel UT, Benali A (2008) High-
and low-frequency repetitive transcranial magnetic stimulation
differentially activates c-Fos and zif268 protein expression in the
rat brain. Exp Brain Res 188:249–261
Berlim MT, Neufeld NH, Van den Eynde F (2013) Repetitive
transcranial magnetic stimulation (rTMS) for obsessive-compul-
sive disorder (OCD): an exploratory meta-analysis of random-
ized and sham-controlled trials. J Psychiatr Res 47:999–1006
Brickman AM, Habeck C, Zarahn E, Flynn J, Stern Y (2007)
Structural MRI covariance patterns associated with normal aging
and neuropsychological functioning. Neurobiol Aging
28:284–295
Demirtas-Tatlidede A, Vahabzadeh-Hagh AM, Pascual-Leone A
(2013) Can noninvasive brain stimulation enhance cognition in
neuropsychiatric disorders? Neuropharmacology 64:566–578
Doi W, Sato D, Fukuzako H, Takigawa M (2001) c-Fos expression in
rat brain after repetitive transcranial magnetic stimulation.
Neuroreport 12:1307–1310
Drane DL, Meador KJ (2002) Cognitive and behavioral effects of
antiepileptic drugs. Epilepsy Behav 3:49–53
Elie D, Poirier M, Chianetta J, Durand M, Gregoire C, Grignon S
(2009) Cognitive effects of antipsychotic dosage and polyphar-
macy: a study with the BACS in patients with schizophrenia and
schizoaffective disorder. J Psychopharmacol
A systematic review of the effects of low-frequency repetitive transcranial magnetic…
123
Figiel GS, Epstein C, McDonald WM, Amazon-Leece J, Figiel L,
Saldivia A, Glover S (1998) The use of rapid-rate transcranial
magnetic stimulation (rTMS) in refractory depressed patients.
J Neuropsychiatr Clin Neurosci 10:20–25
Fitzgerald PB, Brown TL, Daskalakis ZJ, Chen R, Kulkarni J (2002)
Intensity-dependent effects of 1 Hz rTMS on human corti-
cospinal excitability. Clin Neurophysiol 113:1136–1141
Fitzgerald PB, Benitez J, Daskalakis JZ, Brown TL, Marston NA, De
Castella A, Kulkarni J (2005) A double-blind sham-controlled
trial of repetitive transcranial magnetic stimulation in the
treatment of refractory auditory hallucinations. J Clin Psy-
chopharmacol 25:358–362
Fitzgerald PB, Hoy K, Daskalakis ZJ, Kulkarni J (2009) A
randomized trial of the anti-depressant effects of low- and
high-frequency transcranial magnetic stimulation in treatment-
resistant depression. Depression Anxiety 26:229–234
Fregni F et al (2006a) Homeostatic effects of plasma valproate levels
on corticospinal excitability changes induced by 1 Hz rTMS in
patients with juvenile myoclonic epilepsy. Clin Neurophysiol
117:1217–1227
Fregni F et al (2006b) A sham-controlled trial of a 5-day course of
repetitive transcranial magnetic stimulation of the unaffected
hemisphere in stroke patients. Stroke 37:2115–2122
Fregni F et al (2006c) A randomized clinical trial of repetitive
transcranial magnetic stimulation in patients with refractory
epilepsy. Ann Neurol 60:447–455
Gough PM, Nobre AC, Devlin JT (2005) Dissociating linguistic
processes in the left inferior frontal cortex with transcranial
magnetic stimulation. J Neurosci 25:8010–8016
Green S (2011) Cochrane handbook for systematic reviews of
interventions version 5.1. 0 [updated March 2011] The Cochrane
Collaboration
Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of
cognition and functional outcome in schizophrenia: implications
for MATRICS. Schizophr Res 72:41–51
Greenberg BD et al (1997) Effect of prefrontal repetitive transcranial
magnetic stimulation in obsessive-compulsive disorder: a pre-
liminary study. Am J Psychiatry 154:867–869
Guse B, Falkai P, Wobrock T (2010) Cognitive effects of high-
frequency repetitive transcranial magnetic stimulation: a sys-
tematic review. J Neural Transm 117:105–122
Guse B, Falkai P, Gruber O, Whalley H, Gibson L, Hasan A, Obst K,
Dechent P, McIntosh A, Suchan B, Wobrock T (2013) The effect
of long-term high frequency repetitive transcranial magnetic
stimulation on working memory in schizophrenia and healthy
controls - a randomized placebo controlled, double-blind fMRI
study. Behav Brain Res 237:300–307
Hansen PEB et al (2011) Low-frequency repetitive transcranial
magnetic stimulation inferior to electroconvulsive therapy in
treating depression. J ECT 27:26–32
Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt-Lecuona C
(2001) Transcranial magnetic stimulation in therapy studies:
examination of the reliability of A¨u´standard, A¨u` coil positioning
by neuronavigation. Biol Psychiatry 50:58–61
Herwig U, Lampe Y, Juengling FD, Wunderlich A, Walter H, Spitzer
M, Scho¨nfeldt-Lecuona C (2003) Add-on rTMS for treatment of
depression: a pilot study using stereotaxic coil-navigation
according to PET data. J Psychiatr Res 37:267–275
Hoffman RE et al (2005) Temporoparietal transcranial magnetic
stimulation for auditory hallucinations: safety, efficacy and
moderators in a fifty patient sample. Biol Psychiatry
58:97–104
Hoffman RE, Wu K, Pittman B, Cahill JD, Hawkins KA, Fernandez
T, Hannestad J (2013) Transcranial magnetic stimulation of
Wernicke, A¨oˆs and right homologous sites to curtail, A¨u´voices,
A¨u`: a randomized trial. Biol Psychiatr 73:1008–1014
Hoogendam JM, Ramakers GM, Di Lazzaro V (2010) Physiology of
repetitive transcranial magnetic stimulation of the human brain
Brain stimulation 3:95–118
Hoppner J, Schulz M, Irmisch G, Mau R, Schlufke D, Richter J
(2003) Antidepressant efficacy of two different rTMS proce-
dures. Eur Arch Psychiatry Clin Neurosci 253:103–109
Hori H, Yoshimura R, Katsuki A, Hayashi K, Ikenouchi-Sugita A,
Umene-Nakano W, Nakamura J (2012) The cognitive profile of
aripiprazole differs from that of other atypical antipsychotics in
schizophrenia patients. J Psychiatr Res 46:757–761
Hovington CL, McGirr A, Lepage M, Berlim MT (2013) Repetitive
transcranial magnetic stimulation (rTMS) for treating major
depression and schizophrenia: a systematic review of recent
meta-analyses. Ann Med 45:308–321. doi:10.3109/07853890.
2013.783993
Hulme SR, Jones OD, Abraham WC (2013) Emerging roles of
metaplasticity in behaviour and disease. Trends Neurosci
36:353–362
Iyer MB, Schleper N, Wassermann EM (2003) Priming stimulation
enhances the depressant effect of low-frequency repetitive
transcranial magnetic stimulation. J Neurosci 23:10867–10872
Januel D et al (2006) A double-blind sham controlled study of right
prefrontal repetitive transcranial magnetic stimulation (rTMS):
therapeutic and cognitive effect in medication free unipolar
depression during 4 weeks. Prog Neuropsychopharmacol Biol
Psychiatry 30:126–130
Jasper HH (1958) The ten twenty electrode system of the international
federation. Electroencephalogr Clin Neurophysiol 10:371–375
Kang JI, Kim C-H, Namkoong K, Lee CI, Kim SJ (2009) A
randomized controlled study of sequentially applied repetitive
transcranial magnetic stimulation in obsessive-compulsive dis-
order. J Clin Psychiatr 70:1645–1651
Khedr E, Abdel-Fadeil M, Farghali A, Qaid M (2009) Role of 1 and
3 Hz repetitive transcranial magnetic stimulation on motor
function recovery after acute ischaemic stroke. Eur J Neurol
16:1323–1330
Khedr E, Abo-Elfetoh N, Rothwell J, El-Atar A, Sayed E, Khalifa H
(2010) Contralateral versus ipsilateral rTMS of temporoparietal
cortex for the treatment of chronic unilateral tinnitus: compar-
ative study. Eur J Neurol 17:976–983
Kim Y-H et al (2006) Repetitive transcranial magnetic stimulation-
induced corticomotor excitability and associated motor skill
acquisition in chronic stroke. Stroke 37:1471–1476
Kim BR, Kim D-Y, Chun MH, Yi JH, Kwon JS (2010) Effect of
repetitive transcranial magnetic stimulation on cognition and
mood in stroke patients: a double-blind, sham-controlled trial.
Am J Phys Med Rehabil 89:362–368
Kleinjung T et al (2005) Long-term effects of repetitive transcranial
magnetic stimulation (rTMS) in patients with chronic tinnitus.
Otolaryngol Head Neck Surg 132:566–569
Koren D, Shefer O, Chistyakov A, Kaplan B, Feinsod M, Klein E
(2001) Neuropsychological effects of prefrontal slow rTMS in
normal volunteers: a double-blind sham-controlled study. J Clin
Exp Neuropsychol 23:424–430
Landgrebe M et al (2013) P 111. Repetitive transcranial magnetstim-
ulation (rTMS) for the treatment of chronic tinnitus: results of
the german multicenter study. Clin Neurophysiol 124:e117–e118
Lang N, Siebner HR, Ernst D, Nitsche MA, Paulus W, Lemon RN,
Rothwell JC (2004) Preconditioning with transcranial direct
current stimulation sensitizes the motor cortex to rapid-rate
transcranial magnetic stimulation and controls the direction of
after-effects. Biol Psychiatry 56:634–639
Lang N, Harms J, Weyh T, Lemon RN, Paulus W, Rothwell JC,
Siebner HR (2006) Stimulus intensity and coil characteristics
influence the efficacy of rTMS to suppress cortical excitability.
Clin Neurophysiol 117:2292–2301
Lage et al.
123
Langguth B, Eichhammer P, Wiegand R, Marienhegen J, Maenner P,
Jacob P, Hajak G (2003) Neuronavigated rTMS in a patient with
chronic tinnitus. Effects of 4 weeks treatment. NeuroReport
14:980–997
Lefaucheur J-P (2010) Why image-guided navigation becomes
essential in the practice of transcranial magnetic stimulation.
Clin Neurophysiol 40:1–5
Liberati A et al (2009) The PRISMA statement for reporting
systematic reviews and meta-analyses of studies that evaluate
health care interventions: explanation and elaboration. Ann
Intern Med 151:W-65–W-94
Lisanby SH, Gutman D, Luber B, Schroeder C, Sackeim HA (2001)
Sham TMS: intracerebral measurement of the induced electrical
field and the induction of motor-evoked potentials. Biol Psychi-
atry 49:460–463
Little JT et al (2000) Cognitive effects of 1-and 20-hertz repetitive
transcranial magnetic stimulation in depression: preliminary
report. Cognit Behav Neurol 13:119
Loo CK, Taylor JL, Gandevia SC, McDarmont BN, Mitchell PB,
Sachdev PS (2000) Transcranial magnetic stimulation (TMS) in
controlled treatment studies: are some, A¨u´sham, A¨u` forms
active? Biol Psychiatry 47:325–331
Luber B et al (2008) Remediation of sleep-deprivation-induced
working memory impairment with fMRI-guided transcranial
magnetic stimulation. Cereb Cortex 18:2077–2085
Mantovani A, Simpson HB, Fallon BA, Rossi S, Lisanby SH (2010)
Randomized sham-controlled trial of repetitive transcranial
magnetic stimulation in treatment-resistant obsessive-compul-
sive disorder. Int J Neuropsychopharmacol 13:217–227
Martis B, Alam D, Dowd SM, Hill SK, Sharma RP, Rosen C, Pliskin
N, Martin E, Carson V, Janicak PG (2003) Neurocognitive
effects of repetitive transcranial magnetic stimulation in severe
depression. Clin Neurophysiol 114(6):1125–1132
McIntosh AM, Semple D, Tasker K, Harrison LK, Owens DG,
Johnstone EC, Ebmeier KP (2004) Transcranial magnetic
stimulation for auditory hallucinations in schizophrenia. Psychi-
atry Res 127:9–17
Minelli A, Bortolomasi M, Scassellati C, Salvoro B, Avesani M,
Manganotti P (2010) Effects of intravenous antidepressant drugs
on the excitability of human motor cortex: a study with paired
magnetic stimulation on depressed patients. Brain Stimul
3:15–21
Miniussi C, Rossini PM (2011) Transcranial magnetic stimulation in
cognitive rehabilitation. Neuropsychol Rehabilitat 21:579–601
Miniussi C, Ruzzoli M, Walsh V (2010) The mechanism of
transcranial magnetic stimulation in cognition. Cortex
46:128–130
Mogg A et al (2007) Repetitive transcranial magnetic stimulation for
negative symptoms of schizophrenia: a randomized controlled
pilot study. Schizophr Res 93:221–228
Nahas Z et al (2004) Safety and benefits of distance-adjusted
prefrontal transcranial magnetic stimulation in depressed
patients 55–75 years of age: a pilot study. Depress Anxiety
19:249–256
Nahas Z et al (2007) Methods of administering transcranial magnetic
stimulation. In: George MS, Belmaker RH (eds) Transcranial
magnetic stimulation in clinical psychiatry. American Psychi-
atric Publishing Inc, Washington DC, pp 39–59
Palmieri MG, Iani C, Scalise A, Desiato MT, Loberti M, Telera S,
Caramia MD (1999) The effect of benzodiazepines and
flumazenil on motor cortical excitability in the human brain.
Brain Res 815:192–199
Paulus W et al (2008) State of the art: pharmacologic effects on
cortical excitability measures tested by transcranial magnetic
stimulation Brain stimulation 1:151–163
Pell GS, Roth Y, Zangen A (2011) Modulation of cortical excitability
induced by repetitive transcranial magnetic stimulation: influ-
ence of timing and geometrical parameters and underlying
mechanisms. Prog Neurobiol 93:59–98
Rektorova I, Megova S, Bares M, Rektor I (2005) Cognitive
functioning after repetitive transcranial magnetic stimulation in
patients with cerebrovascular disease without dementia: a pilot
study of seven patients. J Neurol Sci 229:157–161
Ridding MC, Rothwell JC (2007) Is there a future for therapeutic use
of transcranial magnetic stimulation? Nat Rev Neurosci
8:559–567
Robol E, Fiaschi A, Manganotti P (2004) Effects of citalopram on the
excitability of the human motor cortex: a paired magnetic
stimulation study. J Neurol Sci 221:41–46
Rossi S et al (2001) Prefontal cortex in long-term memory: an
interference approach using magnetic stimulation. Nat Neurosci
4:948–952
Rossi S, Hallett M, Rossini PM, Pascual-Leone A (2009) Safety,
ethical considerations, and application guidelines for the use of
transcranial magnetic stimulation in clinical practice and
research. Clin Neurophysiol 120:2008–2039
Rusjan PM, Barr MS, Farzan F, Arenovich T, Maller JJ, Fitzgerald
PB, Daskalakis ZJ (2010) Optimal transcranial magnetic stim-
ulation coil placement for targeting the dorsolateral prefrontal
cortex using novel magnetic resonance image-guided neuronav-
igation. Hum Brain Mapp 31:1643–1652
Schachter SC (2007) Currently available antiepileptic drugs. Neu-
rotherapeutics 4:4–11
Schaller G, Lenz B, Friedrich K, Dygon D, Richter-Schmidinger T,
Sperling W, Kornhuber J (2013) No evidence for effects of a
high-frequency repetitive transcranial stimulation series on
verbal and figural fluency and TAP task performance in healthy
male volunteers. Neuropsychobiology 67(2):69–73
Schneider AL, Schneider TL, Stark H (2008) Repetitive transcranial
magnetic stimulation (rTMS) as an augmentation treatment for
the negative symptoms of schizophrenia: a 4-week randomized
placebo controlled study. Brain Stimul 1:106–111
Schulze-Rauschenbach SC, Harms U, Schlaepfer TE, Maier W,
Falkai P, Wagner M (2005) Distinctive neurocognitive effects of
repetitive transcranial magnetic stimulation and electroconvul-
sive therapy in major depression. Br J Psychiatry 186:410–416
Siebner HR, Lang N, Rizzo V, Nitsche MA, Paulus W, Lemon RN,
Rothwell JC (2004) Preconditioning of low-frequency repetitive
transcranial magnetic stimulation with transcranial direct current
stimulation: evidence for homeostatic plasticity in the human
motor cortex. J Neurosci 24:3379–3385
Slotema CW et al (2011) Can low-frequency repetitive transcranial
magnetic stimulation really relieve medication-resistant auditory
verbal hallucinations? Negative results from a large randomized
controlled trial. Biol Psychiatry 69:450–456
Smith JA, Mennemeier M, Bartel T, Chelette KC, Kimbrell T, Triggs
W, Dornhoffer JL (2007) Repetitive transcranial magnetic stim-
ulation for tinnitus: a pilot study. Laryngoscope 117:529–534
Sparing R, Buelte D, Meister IG, Paus T, Fink GR (2008)
Transcranial magnetic stimulation and the challenge of coil
placement: a comparison of conventional and stereotaxic neu-
ronavigational strategies. Hum Brain Mapp 29:82–96
Speer AM, Repella JD, Figueras S, Demian NK, Kimbrell TA,
Wasserman EM, Post RM (2001) Lack of adverse cognitive
effects of 1 Hz and 20 Hz repetitive transcranial magnetic
stimulation at 100% of motor threshold over left prefrontal
cortex in depression. J ECT 17:259–263
Stokes MG, Chambers CD, Gould IC, Henderson TR, Janko NE,
Allen NB, Mattingley JB (2005) Simple metric for scaling motor
threshold based on scalp-cortex distance: application to studies
A systematic review of the effects of low-frequency repetitive transcranial magnetic…
123
using transcranial magnetic stimulation. J Neurophysiol
94:4520–4527
Stokes MG, Chambers CD, Gould IC, English T, McNaught E,
McDonald O, Mattingley JB (2007) Distance-adjusted motor
threshold for transcranial magnetic stimulation. Clin Neurophys-
iol 118:1617–1625
Stuss DT (2011) The future of cognitive neurorehabilitation.
Neuropsychol Rehabilitat 21:755–768
Su T-P, Huang C-C, Wei I-H (2005) Add-on rTMS for medication-
resistant depression: a randomized, double-blind, sham-con-
trolled trial in Chinese patients. J Clin Psychiatr 66:930–937
Takeuchi N, Tada T, Toshima M, Chuma T, Matsuo Y, Ikoma K
(2008) Inhibition of the unaffected motor cortex by 1 Hz
repetitive transcranial magnetic stimulation enhances motor
performance and training effect of the paretic hand in patients
with chronic stroke. J Rehabil Med 40:298–303
Thiel A et al (2013) Effects of noninvasive brain stimulation on
language networks and recovery in early poststroke aphasia.
Stroke 44:2240–2246
Tracy DK, David AS (2015) Clinical neuromodulation in psychiatry:
the state of the art or an art in a state? Current evidence and
future challenges. BJPsych Advances 21:396–404
Tracy DK et al (2011) It’s not what you say but the way that you say
it: an fMRI study of differential lexical and non-lexical prosodic
pitch processing. BMC Neurosci 12:128
Tracy DK, de Sousa de Abreu M, Nalesnik N, Mao L, Lage C,
Shergill SS (2014). Neuroimaging effects of 1Hz right temporo-
parietal rTMS on normal auditory processing: implications for
clinical hallucination treatment paradigms. J Clin Neurophys
31(6):541–546
Tracy DK, Shergill SS, David AS, Fonagy P, Zaman R, Downar J,
Eliott E, Bhui K (2015). Self-harm and suicidal acts: a
suitable case for treatment of impulsivity-driven behaviour with
repetitive transcranial magnetic stimulation (rTMS). BJPsych
Open 1(1):87–91
Van den Eynde F et al (2010) Repetitive transcranial magnetic
stimulation reduces cue-induced food craving in bulimic disor-
ders. Biol Psychiatry 67:793–795
Van den Eynde F, Guillaume S, Broadbent H, Campbell I, Schmidt U
(2013) Repetitive transcranial magnetic stimulation in anorexia
nervosa: a pilot study. Eur Psychiatry 28:98–101
Waldowski K, Seniew J, Leoniak M, Iwanski S, Czonkowska A
(2012) Effect of low-frequency repetitive transcranial magnetic
stimulation on naming abilities in early-stroke aphasic patients: a
prospective, randomized, double-blind sham-controlled study.
Sci World J
Wassermann E, Epstein C, Ziemann U (2008) Oxford handbook of
transcranial stimulation. Oxford University Press
Watts BV, Landon B, Groft A, Young-Xu Y (2012) A sham
controlled study of repetitive transcranial magnetic stimulation
for posttraumatic stress disorder. Brain Stimul 5:38–43
Wielgos M, Cunningham WR, Cynthia (1999) Age-related slowing
on the digit symbol task: longitudinal and cross-sectional
analyses. Exp Aging Res 25:109–120
Lage et al.
123
